Showing results (2271-2280 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 25, 2002
The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expressionGabriel A Rabinovich, Natalia Rubinstein, Pablo Matar, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2001
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cellsL Ragnarsson, T Strömberg, J Wijdenes, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 2001
A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphomaS Laxmanan, G W Stuart, S K Ghosh
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemiaTheresia M Westers, Anita G M Stam, Rik J Scheper, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal typeStefania Zanussi, Emanuela Vaccher, Cristina Caffau, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigenMark Smithers, Kathleen O'Connell, Susan MacFadyen, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2003
Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cellsAxel C P Diederichsen, J v B Hjelmborg, Per B Christensen, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2003
Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cellsOystein Bruserud, Elling Ulvestad
Cancer Immunology, Immunotherapy : CII|April 2, 2003
Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regressionAgnieszka Masztalerz, Nico Van Rooijen, Willem Den Otter, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2003
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladderEtsuya Watanabe, Hideyasu Matsuyama, Kenji Matsuda, et al.
Pageof 652